U.S. markets open in 8 hours 45 minutes
  • S&P Futures

    3,810.25
    -11.00 (-0.29%)
     
  • Dow Futures

    30,925.00
    -74.00 (-0.24%)
     
  • Nasdaq Futures

    11,654.50
    -36.50 (-0.31%)
     
  • Russell 2000 Futures

    1,716.40
    -5.00 (-0.29%)
     
  • Crude Oil

    109.94
    +0.16 (+0.15%)
     
  • Gold

    1,816.70
    -0.80 (-0.04%)
     
  • Silver

    20.63
    -0.04 (-0.18%)
     
  • EUR/USD

    1.0457
    +0.0013 (+0.13%)
     
  • 10-Yr Bond

    3.0930
    0.0000 (0.00%)
     
  • Vix

    28.16
    -0.20 (-0.71%)
     
  • GBP/USD

    1.2129
    +0.0007 (+0.05%)
     
  • USD/JPY

    136.5650
    +0.0200 (+0.01%)
     
  • BTC-USD

    20,054.63
    -262.29 (-1.29%)
     
  • CMC Crypto 200

    430.83
    -8.84 (-2.01%)
     
  • FTSE 100

    7,312.32
    -11.09 (-0.15%)
     
  • Nikkei 225

    26,422.99
    -381.61 (-1.42%)
     

Top Stock Reports for salesforce, Thermo Fisher & Royal Dutch Shell

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·6 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Tuesday, July 6, 2021

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including salesforce.com (CRM), Thermo Fisher Scientific (TMO), and Royal Dutch Shell (RDS.A). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Shares of salesforce have underperformed the Zacks Computer Software industry in the year-to-date period (+11.6% vs. +21.7%). The Zacks analyst believes that the company is benefiting from a robust demand environment as customers are undergoing a major digital transformation. The rapid adoption of its cloud-based solutions has been driving demand for its products.

Furthermore, the recent deal to acquire Slack would position the company to be a leader in enterprise team collaboration solution space and better compete with Microsoft’s Teams product. However, unfavorable currency fluctuations along with increasing investments in international expansions and data centers are an overhang on near-term profitability.

(You can read the full research report on salesforce here >>>)

Thermo Fisher’s shares have gained +10.2% over the past three months against the Zacks Medical Instruments industry’s gain of +11.1%. The Zacks analyst believes that Thermo Fisher is expanding its inorganic growth profile with several takeovers including Advanced Bioprocessing buyout from BD and Patheon.

The company delivered an outstanding performance in the first quarter of 2021 on the back of accelerated growth in its Base business. Further, in terms of end market, the pharma and biotech segments also registered impressive growth. However, the pandemic has massively disrupted the global supply chain. Foreign currency fluctuations and competitive landscape are other major downsides.

(You can read the full research report on Thermo Fisher here >>>)

Shares of Royal Dutch Shell have gained +4.1% in the last six months against the Zacks International Integrated Oil industry’s gain of +22.6%. The Zacks analyst believes that with LNG demand likely to rise significantly in the near-to-medium term, Shell’s position as a major supplier of LNG should help the company meet the fuel’s growing demand, thereby improving cash flow.

Meanwhile, the company is also making solid progress toward the transition to a renewable energy-focused future. However, Shell hasn’t been immune to the coronavirus-induced energy downturn and is also facing some headwinds on the production front. There are also worries over the company’s poor reserve replacement ratio of just 65%.

(You can read the full research report on Royal Dutch Shell here >>>)

Other noteworthy reports we are featuring today include NextEra Energy (NEE), Citigroup (C) and Starbucks (SBUX).

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

salesforce (CRM) Rides on Portfolio Strength and Buyouts

Global Business Aids Thermo Fisher (TMO) Amid Forex Woes

Shell (RDS.A) Aided by LNG Demand Amid Production Woes

Featured Reports

Steady Investment & Renewable Focus Aid NextEra Energy (NEE)

Per the Zacks analyst, NextEra's planned investment to enhance clean electricity generation and strengthen its infrastructure will boost its profitability.

Citi's (C) Streamlining Efforts Aid Amid Falling Fee Income

Per the Zacks analyst, Citigroup's efforts to grow core businesses by streamlining operations are impressive.

Starbucks (SBUX) Banks on Expansion Efforts, Debts High

Per the Zacks analyst, Starbucks' focus on unit expansion in new and existing markets along with remodeling initiatives bode well.

Organic Growth Aids Goldman Sachs (GS), Cost Woes Prevail

Per Zacks analyst, business diversification along with a sound capital position is likely to aid Goldman Sachs' (GS) growth.

Innovation & Improving End Markets to Drive Deere (DE)

Per the Zacks analyst, Deere will gain on its focus on launching products with advanced features as well as strong agricultural markets and improving construction demand.

Digital Transformation, AI Proliferation Aid Infosys (INFY)

Per the Zacks analyst, Infosys is benefiting from large deal wins and higher investments in digital transformation, artificial intelligence, and automation.

Ford (F) Rides on Aggressive EV Plans & Acquisitions

The Zacks analyst appreciates Ford's more than $30 billion investment plan on electric vehicles and acquisition of Electriphi for fleet-depot charging, which is set to boost its e-mobility game.

New Upgrades

Range Resources (RRC) Gains From Non-Core Asset Divestments

The Zacks analyst appreciates Range Resources' asset-divestment initiatives. The natural gas producer will utilize the proceeds to enhance its liquidity profile and reduce debt.

Papa John's (PZZA) Rides On Expansion & Digital Initiatives

Per the Zacks analyst, Papa John's is benefitting from unit expansion efforts, solid comps growth and loyalty program.

Healthy Pipeline of Projects to Benefit Macquarie (MIC)

Per the Zacks analyst, Macquarie's solid pipeline of projects along with its growth investments will continue to lend momentum to the company. Also, its focus on cost-reduction initiatives bodes well.

New Downgrades

Mounting Expenses, Leveraged Balance Sheet Irk QIAGEN (QGEN)

The Zacks analyst is worried about QIAGEN having a lot of debt on its balance sheet. Escalating costs and expenses too are weighing on the company's bottom line.

Pipeline Setbacks, Competition Headwinds For Denali (DNLI)

Per the Zacks analyst, Denali's candidates are years away from commercialization and hence any pipeline setback will be detrimental to its growth prospects. Competition is stiff too.

Columbia Sportswear (COLM) Troubled by Escalated Cost Woes

Columbia Sportswear expects elevated demand creation spending and greater personnel expenses in 2021. Per the Zacks analyst, this is likely to increase the SG&A cost burden.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report
 
Starbucks Corporation (SBUX) : Free Stock Analysis Report
 
Royal Dutch Shell PLC (RDS.A) : Free Stock Analysis Report
 
NextEra Energy, Inc. (NEE) : Free Stock Analysis Report
 
salesforce.com, inc. (CRM) : Free Stock Analysis Report
 
Citigroup Inc. (C) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research